LOGO.png
RAFA To Add Major Component to the Tashkent Pharma Park
17 déc. 2021 11h34 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company “Block” signed an agreement on the implementation of the construction of a...
LOGO.png
Letter to Shareholders from the Chairman of the Board Ilya Shpurov
10 août 2021 10h36 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC: (RAFA) shares the following letter to shareholders from Chairman of the Board Ilya Shpurov: “It is my...
LOGO.png
Rafarma’s Global Pharmaceutical Strategy At A Glance
18 mai 2021 08h53 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern...
Image
Rafarma To Expand Proton Therapy Centers
07 mai 2021 09h35 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings the City Scientific University of Istanbul (Turkey)...
Basic Image
Rafarma and Haifa Technopark Enter Talks for Joint Venture
30 avr. 2021 09h31 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an action plan...
LOGO.png
Rafarma Embarks on Aggressive Global Partnerships Plan
04 mars 2021 10h55 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given...
LOGO.png
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
29 janv. 2021 10h30 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development...
LOGO.png
Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer
09 déc. 2020 09h15 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the previously-announced Biocogency...
LOGO.png
Rafarma Inks Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia
01 déc. 2020 10h53 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia (https://vaccineslab.com/). ...
LOGO.png
Letter To Shareholders from Chairman Ilya Shpurov
09 nov. 2020 09h15 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus , Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov:...